Articles by Eric S. Langer - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Eric S. Langer

Understanding India's New Patent Laws

Did the 2005 Patents Act engender a Western intellectual property rights culture in the country?
Apr 1, 2008

Did the 2005 Patents Act engender a Western intellectual property rights culture in the country?

Biologics Regulation in India

Mar 1, 2008

India is restructuring its regulation of biopharmaceuticals to help the country's industry compete internationally.

Indian Biogenerics: An Evolving Industry

Indian biogenerics could form a major piece of the global biotherapeutics market in the future.
Feb 1, 2008

Indian biogenerics could form a major piece of the global biotherapeutics market in the future.

Biopharmaceuticals in India: A New Era

India has made great strides in the development of its biopharmaceutical industry
Jan 1, 2008

India's biopharmaceutical industry, which was relatively modest only a decade ago, is expected to generate almost $2 billion in sales in 2008, making it one of the largest biopharmaceutical segments in Asia.1 According to BioPlan Associates, Inc., and the Society for Industrial Microbiology's newly published joint study, Advances in Biopharmaceutical Technology in India, the Indian biopharmaceutical industry is growing 25 to 30% per year.1

China as a Biopharmaceutical Powerhouse: Just a Matter of Time

Despite serious obstacles, development marches ahead
Dec 1, 2007

China's pharma industry represents 5% of the world total. By 2010, China is expected to become the world's fifth largest pharmaceutical market.

Biotechnology and Life Sciences Education in China

Changes in the quality of Chinese universities has allowed the biotechnology sector to grow
Nov 1, 2007

Biotechnology is definitely a hot topic in China—the country's administrators recently identified it as a "cornerstone of China's national economy by 2020." But most realize that getting there will require a better trained, specialized workforce than currently exists. The Chinese government has been pumping money into life sciences education as part of its plan to achieve a global biotechnological presence over the next 15 years.

China Today: Biopharmaceutical Exports

Converting China's pharmaceutical manufacturing capacity to biopharmaceutical exports
Aug 1, 2007

In 2006, China exported a total of $890 million in biologics to other countries—a 30.61% increase, compared with the previous year.

Final Word: Are Biotechnology Meetings and Symposia Doing the Job?

The need for speed in scientific discovery may hinder authentic knowledge exchange
Jul 1, 2007

Sir Isaac Newton said, back in 1676, "If I have seen further, it is by standing on the shoulders of Giants." Newton's modest self-assessment of his scientific competence holds relevance in today's debate on the value of scientific meetings, and our quest for faster scientific discovery.

China Today: Biogenerics in China: An Evolving Industry

China's large domestic market potential and its competence in producing biogenerics are driving its future direction
Jun 1, 2007

In China, the presence of a substantial biogenerics industry reflects a growing need to provide healthcare to domestic populations, at a reasonable cost.

ADVERTISEMENT

ADVERTISEMENT

Click here